Home
/
Bioventus Inc.
/
Financials
/
Quarterly
Bioventus Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Bioventus Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 27, 2025
$138.65M
Nov 4, 2025
Q2
2025
Jun 28, 2025
$147.66M
Aug 6, 2025
Q1
2025
Mar 29, 2025
$123.88M
May 6, 2025
Q3
2025
Sep 28, 2024
$138.96M
Nov 4, 2025
Q2
2025
Jun 29, 2024
$151.22M
Aug 6, 2025
Q1
2025
Mar 30, 2024
$129.46M
May 6, 2025
Q3
2024
Sep 30, 2023
$120.79M
Nov 5, 2024
Q2
2024
Jul 1, 2023
$137.07M
Aug 6, 2024
Q1
2024
Apr 1, 2023
$119.06M
May 7, 2024
Q3
2023
Oct 1, 2022
$128.66M
Nov 7, 2023
Q2
2023
Jul 2, 2022
$140.33M
Aug 8, 2023
Q1
2023
Apr 2, 2022
$117.29M
May 16, 2023
Q3
2022
Oct 2, 2021
$108.89M
Nov 21, 2022
Q2
2022
Jul 3, 2021
$109.82M
Aug 12, 2022
Q1
2022
Apr 3, 2021
$81.78M
May 11, 2022
Q3
2021
Sep 26, 2020
$85.91M
Nov 10, 2021
Q2
2021
Jun 27, 2020
$58.02M
Aug 11, 2021
Q1
2021
Mar 28, 2020
$78.65M
May 13, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 27, 2025
$3.16M
Nov 4, 2025
Q2
2025
Jun 28, 2025
$7.46M
Aug 6, 2025
Q1
2025
Mar 29, 2025
($2.64M)
May 6, 2025
Q3
2025
Sep 28, 2024
($5.17M)
Nov 4, 2025
Q2
2025
Jun 29, 2024
($25.68M)
Aug 6, 2025
Q1
2025
Mar 30, 2024
($4.89M)
May 6, 2025
Q3
2024
Sep 30, 2023
($7.30M)
Nov 5, 2024
Q2
2024
Jul 1, 2023
($3.68M)
Aug 6, 2024
Q1
2024
Apr 1, 2023
($139.15M)
May 7, 2024
Q3
2023
Oct 1, 2022
($108.25M)
Nov 7, 2023
Q2
2023
Jul 2, 2022
($7.25M)
Aug 8, 2023
Q1
2023
Apr 2, 2022
($11.28M)
May 16, 2023
Q3
2022
Oct 2, 2021
($1.07M)
Nov 21, 2022
Q2
2022
Jul 3, 2021
($4.13M)
Aug 12, 2022
Q1
2022
Apr 3, 2021
($1.04M)
May 11, 2022
Q3
2021
Sep 26, 2020
$8.46M
Nov 10, 2021
Q2
2021
Jun 27, 2020
($5.77M)
Aug 11, 2021
Q1
2021
Mar 28, 2020
$10.94M
May 13, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 27, 2025
$11.25M
Nov 4, 2025
Q2
2025
Jun 28, 2025
$18.37M
Aug 6, 2025
Q1
2025
Mar 29, 2025
$4.87M
May 6, 2025
Q3
2025
Sep 28, 2024
$3.65M
Nov 4, 2025
Q2
2025
Jun 29, 2024
($31.47M)
Aug 6, 2025
Q1
2025
Mar 30, 2024
$4.93M
May 6, 2025
Q3
2024
Sep 30, 2023
$2.42M
Nov 5, 2024
Q2
2024
Jul 1, 2023
$6.75M
Aug 6, 2024
Q1
2024
Apr 1, 2023
($92.06M)
May 7, 2024
Q3
2023
Oct 1, 2022
($126.84M)
Nov 7, 2023
Q2
2023
Jul 2, 2022
($3.31M)
Aug 8, 2023
Q1
2023
Apr 2, 2022
($21.45M)
May 16, 2023
Q3
2022
Oct 2, 2021
($1.05M)
Nov 21, 2022
Q2
2022
Jul 3, 2021
($5.74M)
Aug 12, 2022
Q1
2022
Apr 3, 2021
$22.00M
May 11, 2022
Q3
2021
Sep 26, 2020
$6.93M
Nov 10, 2021
Q2
2021
Jun 27, 2020
($4.59M)
Aug 11, 2021
Q1
2021
Mar 28, 2020
$12.99M
May 13, 2021